The Sidney & Lois Eskenazi Hospital is a public hospital located in Indianapolis, Indiana. The hospital is the flagship medical center for Eskenazi Health, founded in 1859 as Indiana's oldest public healthcare system. The hospital is operated by Health & Hospital Corporation of Marion County.

There are 315 beds in Wishard Hosp.

During the past decade, Wishard Hosp conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 7 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wishard Hosp" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 20 trials, followed by "Indiana University School of Medicine" with 6 trials sponsored, "Indiana University" with 3 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wishard Hosp" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Boston Medical Center" with 1 trials as a collaborator and "Eastern Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Wishard Hosp" are "HIV Infections" (22 trials), "Cataract" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Hypercholesterolemia" (2 trials) and "Hypertriglyceridemia" (2 trials). Many other conditions were trialed in "Wishard Hosp" in a lesser frequency.

Most popular intervention types in "Wishard Hosp" are "Drug" (26 trials), "Procedure" (3 trials), "Behavioral" (2 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "PF-02341066" (2 trials), "Placebo" (2 trials), "cetuximab" (2 trials), "Alendronate" (1 trials) and "Antiretroviral Treatment Interruption" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wishard Hosp" are 36 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Wishard Hosp". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Wishard Hosp, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Wishard Hosp, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 12 trials that are defined as “Not Applicable".